· Health Care Equipment · S&P SmallCap 600
CNMD CONMED CORP $1.3B
No. They have begun to deploy AI. No use is named.
4 of 15
Reach, Weight, and Proof.
Last updated score 31 AugLast review 29 OctLast earnings call 28 OctNext earnings call not posted yet
What they are doing
CONMED says it has begun to deploy artificial intelligence and other new technology across operations, and that it is still exploring further uses. The filing lists research, manufacturing, and commercialization as places this could matter. It does not name a program, a product, or a result. The surgical tools business is unchanged. The 28 October 2026 call, including the questions, named no artificial-intelligence product. The score stays 4.
Why the score
- Reach 1 not 2: several possible places, none of them a function we can see.
- Weight 1 not 2: begun to deploy and still exploring is not hygiene in production.
- Proof 2 not 3: named in the 10-K and tied to operations. No program in the loop.
What would move it next quarter: A named use in a CONMED product or plant, with a result.
Open these first
Evidence
Our use of artificial intelligence and other emerging technologies could adversely impact our business. We have begun to deploy AI and other emerging technologies in various facets of our operations, and we continue to explore further use cases. The filing points to research, manufacturing, and commercialization as areas of opportunity.